Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chengyong Wu

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Molecular Oncology|March 25, 2023
Long noncoding RNAs with peptide-encoding potential identified in esophageal squamous cell carcinoma: KDM4A-AS1-encoded peptide weakens cancer cell viability and migratory capacityBo Zhou, Yuyang Wu, Pei Cheng, et al.
Cancer Biology & Therapy|March 11, 2024
The relationship between long non-coding gene <i>CASC21</i> polymorphisms and cervical cancerLili Han, Jing Liu, Mireayi Shataer, et al.
European Journal of Medicinal Chemistry|March 10, 2023
RSK inhibitors as potential anticancer agents: Discovery, optimization, and challengesYing Sun, Lichao Tang, Chengyong Wu, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|October 24, 2022
The Low Endometrial Expression of Long Non-Coding RNA NORAD Is Associated with Recurrent Pregnancy Losses and Unexplained InfertilityYing Huang, Chengyong Wu, Chunmei Wei, et al.
Physical Chemistry Chemical Physics : PCCP|October 10, 2025
Hydrophobic interaction-driven binding of ensifentrine stabilizes PDE3A: insights from X-ray crystallography and molecular dynamicsShuangshuang Li, Quanwei Yu, Liyun Bi, et al.
European Journal of Medicinal Chemistry|March 2, 2024
Current advances and development strategies of targeting son of sevenless 1 (SOS1) in drug discoveryJialin Wu, Xiaoxue Li, Chengyong Wu, et al.
Drug Discovery Today|April 26, 2024
Development and therapeutic implications of small molecular inhibitors that target calcium-related channels in tumor treatmentLinxi Zhang, Changyu Ren, Jiao Liu, et al.
European Journal of Medicinal Chemistry|May 31, 2024
Emerging trends in small molecule inhibitors targeting aldosterone synthase: A new paradigm in cardiovascular disease treatmentCuiyu Guo, Guangbing Zhang, Chengyong Wu, et al.
European Journal of Medicinal Chemistry|July 7, 2024
Discovery and mechanistic insights into thieno[3,2-d]pyrimidine and heterocyclic fused pyrimidines inhibitors targeting tubulin for cancer therapyChengyong Wu, Lele Zhang, Zhilan Zhou, et al.
European Journal of Medicinal Chemistry|January 9, 2023
Discovery and biological evaluation of 4,6-pyrimidine analogues with potential anticancer agents as novel colchicine binding site inhibitorsJifa Zhang, Lun Tan, Chengyong Wu, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Molecular Oncology|March 25, 2023
Long noncoding RNAs with peptide-encoding potential identified in esophageal squamous cell carcinoma: KDM4A-AS1-encoded peptide weakens cancer cell viability and migratory capacityBo Zhou, Yuyang Wu, Pei Cheng, et al.
Cancer Biology & Therapy|March 11, 2024
The relationship between long non-coding gene <i>CASC21</i> polymorphisms and cervical cancerLili Han, Jing Liu, Mireayi Shataer, et al.
European Journal of Medicinal Chemistry|March 10, 2023
RSK inhibitors as potential anticancer agents: Discovery, optimization, and challengesYing Sun, Lichao Tang, Chengyong Wu, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|October 24, 2022
The Low Endometrial Expression of Long Non-Coding RNA NORAD Is Associated with Recurrent Pregnancy Losses and Unexplained InfertilityYing Huang, Chengyong Wu, Chunmei Wei, et al.
Physical Chemistry Chemical Physics : PCCP|October 10, 2025
Hydrophobic interaction-driven binding of ensifentrine stabilizes PDE3A: insights from X-ray crystallography and molecular dynamicsShuangshuang Li, Quanwei Yu, Liyun Bi, et al.
European Journal of Medicinal Chemistry|March 2, 2024
Current advances and development strategies of targeting son of sevenless 1 (SOS1) in drug discoveryJialin Wu, Xiaoxue Li, Chengyong Wu, et al.
Drug Discovery Today|April 26, 2024
Development and therapeutic implications of small molecular inhibitors that target calcium-related channels in tumor treatmentLinxi Zhang, Changyu Ren, Jiao Liu, et al.
European Journal of Medicinal Chemistry|May 31, 2024
Emerging trends in small molecule inhibitors targeting aldosterone synthase: A new paradigm in cardiovascular disease treatmentCuiyu Guo, Guangbing Zhang, Chengyong Wu, et al.
European Journal of Medicinal Chemistry|July 7, 2024
Discovery and mechanistic insights into thieno[3,2-d]pyrimidine and heterocyclic fused pyrimidines inhibitors targeting tubulin for cancer therapyChengyong Wu, Lele Zhang, Zhilan Zhou, et al.
European Journal of Medicinal Chemistry|January 9, 2023
Discovery and biological evaluation of 4,6-pyrimidine analogues with potential anticancer agents as novel colchicine binding site inhibitorsJifa Zhang, Lun Tan, Chengyong Wu, et al.
Pageof 6